Intratumoral CD45+CD71+ erythroid cells induce immune tolerance and predict tumor recurrence in hepatocellular carcinoma

Jie Chen,Yi-Dan Qiao,Xing Li,Jian-Liang Xu,Qing-Jian Ye,Nan Jiang,Hui Zhang,Xiang-Yuan Wu

DOI: https://doi.org/10.1016/j.canlet.2020.12.003

IF: 9.756

2021-02-01

Cancer Letters

Abstract:<p>CD45⁺CD71⁺ erythroid cells generated through splenic extramedullary erythropoiesis have recently been found to suppress anti-infection and tumor immunity in neonates and adults with malignances. However, their role in tumor microenvironment has not been investigated. In the present study, we found that the number of CD45⁺CD71⁺ erythroid cells was significantly elevated in hepatocellular carcinoma (HCC) tissues compared to that in paratumor region and circulation. Additionally, they were more abundant in HCC tissues compared to some immune suppressive cells as well as CD45⁻CD71⁺ erythroid cells. CD45⁺CD71⁺ erythroid cells suppressed T cells through generation of reactive oxygen species, IL-10, and TGF-β in a paracrine and cell-cell contact manner, and their suppressive effect was stronger than that of myeloid-derived suppressor cells. The abundance of CD45⁺CD71⁺ erythroid cells in tumor tissue, as illustrated via immunofluorescence, predicted disease-free survival and overall survival, and its prognostic value was better than that of Cancer of the Liver Italian Program score. This study demonstrated that accumulation of intratumoral CD45⁺CD71⁺ erythroid cells in HCC tissues could play a superior immunosuppressive role in tumor microenvironment and may serve as a valuable biomarker to predict recurrence of HCC.</p>

oncology

What problem does this paper attempt to address?

### Problems the paper attempts to solve

This paper aims to explore the role of a special cell in the tumor microenvironment - **intratumoral CD45+CD71+ erythroid cells** in hepatocellular carcinoma (HCC). Specifically, the researchers hope to answer the following questions:

1. **Are these cells enriched in HCC tissues?**
- The researchers detected the number of CD45+CD71+ erythroid cells in the blood and tissue samples of HCC patients by methods such as flow cytometry and immunofluorescence staining, and compared them with healthy control groups and patients with chronic hepatitis B (CHB).

2. **Do these cells have immunosuppressive functions?**
- Through in - vitro experiments, the researchers evaluated the inhibitory effect of CD45+CD71+ erythroid cells on T - cell proliferation and activation. They used CFSE - labeled T - cells and co - culture systems, as well as cytokine detection methods.

3. **Are these cells related to the prognosis of HCC patients?**
- The researchers analyzed the relationship between the abundance of CD45+CD71+ erythroid cells in HCC tissues and the disease - free survival (DFS) and overall survival (OS) of patients. They used statistical methods such as Kaplan - Meier curves and log - rank tests to evaluate the prognostic value of these cells.

### Main findings

1. **The number of CD45+CD71+ erythroid cells significantly increases in HCC patients**:
- Compared with healthy control groups and CHB patients, the number of CD45+CD71+ erythroid cells in the blood and tissues of HCC patients significantly increases. Especially in HCC tissues, the number of these cells is about 10 times higher than that in the surrounding normal tissues and blood.

2. **CD45+CD71+ erythroid cells have strong immunosuppressive functions**:
- In - vitro experiments show that CD45+CD71+ erythroid cells can inhibit the proliferation and activation of T - cells in a direct cell - contact and paracrine manner by generating factors such as reactive oxygen species (ROS), IL - 10 and TGF - β. Its inhibitory effect is stronger than that of myeloid - derived suppressor cells (MDSCs).

3. **The abundance of CD45+CD71+ erythroid cells is related to the poor prognosis of HCC patients**:
- The results of immunofluorescence staining show that the abundance of CD45+CD71+ erythroid cells in HCC tissues is negatively correlated with the DFS and OS of patients. Its prognostic value is better than that of the Cancer of the Liver Italian Program (CLIP) score.

### Conclusion

This study reveals the important immunosuppressive role of CD45+CD71+ erythroid cells in the HCC tumor microenvironment and proposes that these cells may be potential biomarkers for predicting HCC recurrence. This finding provides new targets and ideas for the immunotherapy of HCC.